Intro

This chapter analyzes Abstract 501 from the Jackpot study discussed at ACR 2024, focusing on the safety and effectiveness of JAK inhibitors versus other treatment options for rheumatoid arthritis. The findings indicate that both JAK and TNF inhibitors provide quicker relief in pain and enhance patient-reported outcomes within the initial treatment phase.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app